Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

NCT04383210 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

54

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Locally Advanced Solid Tumor
Metastatic Solid Tumor
Pancreatic Cancer
Lung Cancer
Head and Neck Cancer
Breast Cancer
Kidney Cancer
Colorectal Cancer
Bladder Cancer
Ovarian Cancer
Sarcoma
Gallbladder Cancer
Bile Duct Cancer
Esophageal Cancer
Uterine Cancer
Cholangiocarcinoma
Prostate Cancer

Interventions

DRUG: Seribantumab

Sponsor

Elevation Oncology